Ghaith K. Mansour

Riyadh, 11533, Saudi Arabia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Generative Artificial Intelligence Transitions Pharmaceutical Development from Empirical Screening to Predictive Molecular Design and Clinical Trial Optimization.

Generative Artificial Intelligence Transitions Pharmaceutical Development from Empirical Screening to Predictive Molecular Design and Clinical Trial Optimization.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: March 05, 2026

Xanomeline-Trospium Validates Muscarinic Agonism as an Effective Non-Dopaminergic Treatment for Schizophrenia.

Xanomeline-Trospium Validates Muscarinic Agonism as an Effective Non-Dopaminergic Treatment for Schizophrenia.

Journal: International journal of molecular sciences

Published: March 02, 2026

Anemia as a Potent and Underrecognized Driver of Venous Thromboembolism: A Systematic Review.

Anemia as a Potent and Underrecognized Driver of Venous Thromboembolism: A Systematic Review.

Journal: Journal of clinical medicine

Published: December 01, 2025

Beyond attenuation: a translational review of curative-intent pharmacological targets in idiopathic pulmonary fibrosis.

Beyond attenuation: a translational review of curative-intent pharmacological targets in idiopathic pulmonary fibrosis.

Journal: Frontiers in medicine

Published: November 17, 2025

From neuroinflammation to neural inference: computational psychiatry meets precision medicine.

From neuroinflammation to neural inference: computational psychiatry meets precision medicine.

Journal: Schizophrenia (Heidelberg, Germany)

Published: November 16, 2025

Hormonal and Behavioral Consequences of Social Isolation and Loneliness: Neuroendocrine Mechanisms and Clinical Implications.

Hormonal and Behavioral Consequences of Social Isolation and Loneliness: Neuroendocrine Mechanisms and Clinical Implications.

Journal: International journal of molecular sciences

Published: November 13, 2025

Redox Modulation in Hepatic Fibrosis: Translating NOX1/4 Inhibition to Therapy.

Redox Modulation in Hepatic Fibrosis: Translating NOX1/4 Inhibition to Therapy.

Journal: International journal of molecular sciences

Published: November 12, 2025

The Precision Revolution in Hematologic Malignancies: A Decade of Transformative Immunotherapies and Targeted Agents.

The Precision Revolution in Hematologic Malignancies: A Decade of Transformative Immunotherapies and Targeted Agents.

Journal: Journal of clinical medicine

Published: November 09, 2025

Efgartigimod for Generalized Myasthenia Gravis and Beyond: A Narrative Review of Its Pharmacological Profile, Clinical Utility, and Expanding Applications.

Efgartigimod for Generalized Myasthenia Gravis and Beyond: A Narrative Review of Its Pharmacological Profile, Clinical Utility, and Expanding Applications.

Journal: Biomedicines

Published: November 04, 2025

Neurovascular Dysfunction and Glymphatic Impairment: An Unexplored Therapeutic Frontier in Neurodegeneration.

Neurovascular Dysfunction and Glymphatic Impairment: An Unexplored Therapeutic Frontier in Neurodegeneration.

Journal: International journal of molecular sciences

Published: November 01, 2025

Dual SGLT1/2 inhibition with sotagliflozin: a pharmaceutical breakthrough in heart failure management and cardiometabolic risk reduction.

Dual SGLT1/2 inhibition with sotagliflozin: a pharmaceutical breakthrough in heart failure management and cardiometabolic risk reduction.

Journal: Frontiers in medicine

Published: October 28, 2025

Tezepelumab: redefining TSLP blockade in severe asthma through mechanistic precision and translational pharmacology.

Tezepelumab: redefining TSLP blockade in severe asthma through mechanistic precision and translational pharmacology.

Journal: Frontiers in pharmacology

Published: October 26, 2025

Showing 1-12 of 18

Last Updated: 09/26/2026